NEWS
Our Latest News
ARCHIMED purchases BioVendor Group, a leading global player in advanced diagnostics
Global private equity healthcare specialist ARCHIMED announces the acquisition of BioVendor Group, a major player in advanced diagnostics, with expertise in immunology, infectious, metabolic, and autoimmune diseases as well as genetics research, expanding ARCHIMED’s numerous investments in the diagnostics industry.
ARCHIMED atteint le hard cap pour son fonds II
September
18,
2017
Primo sponsors the Executive Master in Management specialized in Healthcare Business
December
9,
2016
En quête d’entreprises profitables
November
14,
2016
ARCHIMED buys four companies; HIS, Fytexia, Polyplus, and Micromed
September
20,
2016
368